Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to ...

The pharmacy, called NovoCare, will allow patients to pay $499 in cash per month for the blockbuster weight loss drug.

Novo Nordisk ( NVO) announced a new cash-pay option for its blockbuster weight-loss drug Wegovy, offering a monthly dose at $499 and home delivery. The move follows competitor Eli Lilly ( LLY ), which ...

Novo Nordisk's NovoCare will now provide uninsured or underinsured patients access to Wegovy for just $499 per month—less ...

Consumer health company Kenvue said on Wednesday it had appointed three new directors to its board as part of an agreement ...

Novo Nordisk launched NovoCare Pharmacy, to deliver doses of its weight-loss Wegovy drug directly to its users, in a bid to reduce its cost. The Danish pharmaceutical company said Wednesday that the ...

Novo Nordisk (NVO) is advancing 4% after the drug maker cut the price of its very popular weight-loss drug, Wegovy, by over ...

Novo Nordisk plans to offer its Wegovy weight loss drug at a reduced cost of $499 per month for cash-paying customers in the ...

Novo Nordisk is cutting prices on weight-loss drug Wegovy, a week after Eli Lilly did the same for rival Zepbound.

Novo Nordisk (NYSE: NVO) is introducing NovoCare Pharmacy, a direct-to-patient delivery option offering Wegovy at a reduced ...

Investing.com -- Shares of Hims and Hers (NYSE: HIMS) fell 3% amidst news of Novo Nordisk (NYSE: NVO) introducing NovoCare Pharmacy, which directly impacts the competitive landscape by offering ...

Wegovy, like Ozempic, is a brand name for semaglutide and offered to people via prescription when they're having issues with ...